Member Info for Wilson63

Last one from me Tks to Rick

https://twitter.com/rick_shares/status/1388039803577544704

So why after our huge drop are world quant increasing their short what are they oddo(4.1euro target) up to? are there no easier targets out there, really?

So is it fundamentals that displease the markets
Is it forward projections
Is It pipeline of products
Is it lack of cash?
Do we have a huge debt pile?
We have only one product?
We don't deliver on time?
The product doesn't work?
We don't have genomic sequencing capability within a couple of hours?
We don't id all mutations?
Our machines can only be used on our 550/60/70 products(wrong for those unsure)
We haven't got any airport testing capability.
We don't have PROmate?

Tesla mcap
Cazoo mcap (can't remember if ipo yet)
Our mcap lol.

Kitzie I didn't post it earlier for that reason
however when you've got some of these all knowing chartist posting retrospective I told you so's it's actually factual.

Must be a day for it andydeb1 you've not posted since last feb and then your predicting sub 4(yes I'm that bored)

Rigz works for me , and in essence that answers letdowns question, where there's hope the shareholders stay strong, where there's results the sim shareholder walks.

Just a sit and wait here as usual investors are the ones that get bit on the rear ho hum.
Oh well

Held......Holding.........Hold......

Johnnykipper if you reread the Rns and then baring in mind Monday's tweet ......well I'm not sure:(((.

Morning airlineboy surely it was an r and d update so wasn't product launches therefore a bit difficult to separate up.

Anybody read Gdr's Rns which has the last paragraph re pricing which reads as follows

Given the escalating infection rate in the country, this week India began to allow the import of certain COVID test kits with foreign registrations, including CE-Marking, without the need for ICMR approval. The country has also introduced pricing controls into the public market, setting a dynamic that does favour the provision of "basic" tests. The Company believes however that formal performance evaluation data and ICMR approval will contribute positively to commercial efforts and premium products such as gendrive's can play a part in the need for COVID-19 testing.

Very interesting read at 3.45am(why am I awake) I've picked out this bit on genomic sequencing realising it's a general comment any thoughts.

But genomics is not just for tackling this huge problem in rare diseases.

We’re making genomic sequencing a routine part of everyday diagnosis and treatment, and the UK again is uniquely placed.

The NHS has the scale and the systems to make it happen.

Turning tests around more quickly, prescribing precision medicine, giving doctors the tools to make better clinical decisions.

So we’ll be backing genomics to the hilt.

From our side, we need you.

First, I’ve asked the Medical Research Council to develop a proposal for a UK Functional Genomics Initiative, through this initiative we want to make the UK a world leader in new approaches to understanding how genetic changes cause disease, and through that, the validation of drugs targets, later this year we’ll be launching our genome UK Implementation Plan.

And I can confirm that we’re making further investments in some of Genomics England’s most cutting-edge projects, including the sequencing of newborns, in addressing the underrepresentation of ethnic minorities in genomic datasets, and funding next generation approaches to cancer diagnosis.

Genomics is at the cutting edge, it’s helped save lives in this pandemic.

And we in the UK are undisputed world leaders, and we’re going to keep on leading.

Government, industry and academia. That Holy Trinity, working together.

Ad4you yes it is can't read the whole article but will be interesting to hear their slant on things.

https://twitter.com/NovacytGroup/status/1387796869842100224

Butchers bike link from earlier on

https://www.lab-innovations.com/exhibitor/novacyt-group/

21 jobs according to gasman

https://twitter.com/gasman2020/status/1387741653864157190

https://en.wikipedia.org/wiki/Clade

Obviously lol

Company tweet

https://twitter.com/NovacytGroup/status/1387688865482383360

Not got level 2 but somebody's got their money out. Tighter than a drum skin here:))

Morning Amers, I look at it as a foot in the door I suppose and to an extent as we are only a small company we rely on the distributors and as such PROmate and the Q machines are a great help.

Temuchin as companies are all prone to maximising what they can do I'm presuming the additional Q's would mean additional numbers.

All constructive counter views welcome.

Busy on here last night for anybody that missed it look at this link scroll down to tac healthcare link and blow up the pictures and make sure you play spot the q16

https://twitter.com/NewFormsResearc/status/1387460780438732800

Then look at this versalab work sheet and pay particular attention to the right hand column as highlighted by Bladesharp

http://www.primerdesign.co.uk/assets/files/mm137_issue_1_versalab_sales_sheet_1.pdf

All imho dyor

Dazzermans link

https://www.orbispharmareports.com/global-pcr-kit-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread/

I'm off tv time.

Troublesome apologies for late response but I see Kilkenny ted has answered you.

Rampy boom

https://www.tachealthcaregroup.com/2020/07/01/tac-invests-in-latest-technology-to-provide-an-even-faster-covid-19-testing/